Figure 6
From: Specifically targeting ERK1 or ERK2 kills Melanoma cells
Silencing ERK1 and/or ERK2 reduces protein levels of upstream kinases after 4 days including BRAF, CRAF, and phospho MEK; while PD0325901 or PLX4032 exposure variably influences these kinases, with less to no effects of any treatments on BRAF mRNA levels. A. Western blot of upstream kinases in A375 cells 4 days after treatment with shRNAs (left side panel), or after exposure to PD0325901 (1 μM) or PLX4032 (5 μM) on right side panel. GAPDH confirms equivalent protein loading. B. BRAF mRNA levels after 4 days of exposure to PD0325901 orPLX4032 (upper panel); or after treatment with shRNAs (lower panel). Histograms represent the means +/- SD based on three independent experiments.